{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P35354",
      "entity_text" : "COX-2",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-1224" ]
    }
  },
  "verbose_text" : "Interestingly, COX-2 overexpression was associated with worse PSA failure (by ASTRO definition) for those on the control arm of RT + STAD but not those on the RT + LTAD (p = 0.002), suggesting that COX-2 may serve as a predictive biomarker for length of ADT therapy in high-risk and locally advanced prostate cancer patients.",
  "reading_complete" : "2020-07-28T14:17:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T14:04:53Z",
  "trigger" : "overexpression",
  "evidence" : [ "COX-2 overexpression" ],
  "pmc_id" : "3412203",
  "score" : 0
}